111 related articles for article (PubMed ID: 30566923)
1. Can CT imaging improve targeting accuracy in clip-based proton therapy of ocular melanoma?
Slopsema RL; Mamalui M; Bolling J; Flampouri S; Yeung D; Li Z; Rutenberg MS; Dagan R
Phys Med Biol; 2019 Jan; 64(3):035010. PubMed ID: 30566923
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric comparison of stopping power calibration with dual-energy CT and single-energy CT in proton therapy treatment planning.
Zhu J; Penfold SN
Med Phys; 2016 Jun; 43(6):2845-2854. PubMed ID: 27277033
[TBL] [Abstract][Full Text] [Related]
3. Positioning accuracy and daily dose assessment for prostate cancer treatment using in-room CT image guidance at a proton therapy facility.
Maeda Y; Sato Y; Minami H; Yasukawa Y; Yamamoto K; Tamamura H; Shibata S; Bou S; Sasaki M; Tameshige Y; Kume K; Ooto H; Kasahara S; Shimizu Y; Saga Y; Omoya A; Saitou M
Med Phys; 2018 May; 45(5):1832-1843. PubMed ID: 29532489
[TBL] [Abstract][Full Text] [Related]
4. A Monte-Carlo study to assess the effect of 1.5 T magnetic fields on the overall robustness of pencil-beam scanning proton radiotherapy plans for prostate cancer.
Kurz C; Landry G; Resch AF; Dedes G; Kamp F; Ganswindt U; Belka C; Raaymakers BW; Parodi K
Phys Med Biol; 2017 Oct; 62(21):8470-8482. PubMed ID: 29047455
[TBL] [Abstract][Full Text] [Related]
5. Incorporating patient-specific CT-based ophthalmic anatomy in modeling iodine-125 eye plaque brachytherapy dose distributions.
Tien CJ; Astrahan MA; Kim JM; Materin M; Chen Z; Nath R; Liu W
Brachytherapy; 2017; 16(5):1057-1064. PubMed ID: 28778599
[TBL] [Abstract][Full Text] [Related]
6. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
[TBL] [Abstract][Full Text] [Related]
7. Advanced Collapsed cone Engine dose calculations in tissue media for COMS eye plaques loaded with I-125 seeds.
Morrison H; Menon G; Larocque MP; van Veelen B; Niatsetski Y; Weis E; Sloboda RS
Med Phys; 2018 Jul; 45(7):3349-3360. PubMed ID: 29729009
[TBL] [Abstract][Full Text] [Related]
8. 106Ru/106Rh plaque and proton radiotherapy for ocular melanoma: a comparative dosimetric study.
Mourtada F; Koch N; Newhauser W
Radiat Prot Dosimetry; 2005; 116(1-4 Pt 2):454-60. PubMed ID: 16604677
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of MRI-only treatment planning for proton therapy in brain and prostate cancers: Dose calculation accuracy in substitute CT images.
Koivula L; Wee L; Korhonen J
Med Phys; 2016 Aug; 43(8):4634. PubMed ID: 27487880
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric properties of a proton beamline dedicated to the treatment of ocular disease.
Slopsema RL; Mamalui M; Zhao T; Yeung D; Malyapa R; Li Z
Med Phys; 2014 Jan; 41(1):011707. PubMed ID: 24387499
[TBL] [Abstract][Full Text] [Related]
11. Personalized treatment planning in eye brachytherapy for ocular melanoma: Dosimetric analysis on ophthalmic structure at risk.
Itta F; Liuzzi R; Farella A; Porri G; Pacelli R; Conson M; Oliviero C; Buonanno F; Breve MA; Cennamo G; Clemente S; Cella L
Phys Med; 2020 Aug; 76():285-293. PubMed ID: 32738776
[TBL] [Abstract][Full Text] [Related]
12. Investigating the dosimetric impact of seed location uncertainties in Collaborative Ocular Melanoma Study-based eye plaques.
Johnson JE; Deufel CL; Furutani KM
Brachytherapy; 2016; 15(5):661-8. PubMed ID: 27475484
[TBL] [Abstract][Full Text] [Related]
13. The influence of physical wedges on penumbra and in-field dose uniformity in ocular proton beams.
Baker C; Kacperek A
Phys Med; 2016 Apr; 32(4):612-7. PubMed ID: 26988936
[TBL] [Abstract][Full Text] [Related]
14. A novel dose-based positioning method for CT image-guided proton therapy.
Cheung JP; Park PC; Court LE; Ronald Zhu X; Kudchadker RJ; Frank SJ; Dong L
Med Phys; 2013 May; 40(5):051714. PubMed ID: 23635262
[TBL] [Abstract][Full Text] [Related]
15. Technical Note: Dosimetric effects of couch position variability on treatment plan quality with an MRI-guided Co-60 radiation therapy machine.
Chow PE; Thomas DH; Agazaryan N; Cao M; Low DA; Yang Y; Steinberg ML; Lee P; Lamb JM
Med Phys; 2016 Aug; 43(8):4514. PubMed ID: 27487868
[TBL] [Abstract][Full Text] [Related]
16. An improved treatment planning and quality assurance process for Collaborative Ocular Melanoma Study eye plaque brachytherapy.
Weersink RA; Patterson S; Ballantyne H; Di Tomasso A; Borg J; Vitkin A; Rink A; Beiki-Ardakani A
Brachytherapy; 2019; 18(5):658-667. PubMed ID: 31235445
[TBL] [Abstract][Full Text] [Related]
17. Potential and pitfalls of 1.5T MRI imaging for target volume definition in ocular proton therapy.
Via R; Hennings F; Pica A; Fattori G; Beer J; Peroni M; Baroni G; Lomax A; Weber DC; Hrbacek J
Radiother Oncol; 2021 Jan; 154():53-59. PubMed ID: 32890606
[TBL] [Abstract][Full Text] [Related]
18. Secondary neutron doses in proton therapy treatments of ocular melanoma and craniopharyngioma.
Farah J; Sayah R; Martinetti F; Donadille L; Lacoste V; Hérault J; Delacroix S; Nauraye C; Vabre I; Lee C; Bolch WE; Clairand I
Radiat Prot Dosimetry; 2014 Oct; 161(1-4):363-7. PubMed ID: 24222710
[TBL] [Abstract][Full Text] [Related]
19. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.
Rana S; Zheng Y
J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310
[TBL] [Abstract][Full Text] [Related]
20. Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study.
Weber DC; Bogner J; Verwey J; Georg D; Dieckmann K; Escudé L; Caro M; Pötter R; Goitein G; Lomax AJ; Miralbell R
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):373-84. PubMed ID: 16168832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]